Calcificación de aorta abdominal en diabetes mellitus tipo 2: asociación con cardiopatía isquémica y desempeño de un modelo clínico
EndoAr · 2025
DOI: 10.65640/4a1ne585 ↗Kurz gefasst
Fachartikel in der Zeitschrift EndoAr, 2025. Verfasst von Pitasny Vanesa und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is associated with an accelerated development of atherosclerotic vascular disease, which accounts for most of its cardiovascular complications. Abdominal aortic calcification (AAC) has been proposed as a marker of cardiovascular risk. The aim of this study was to describe the clinical and therapeutic profile of patients with T2DM and to evaluate the association between AAC and macrovascular complications. Materials and methods: Cross-sectional observational study of 209 adults with T2DM. Demographic, clinical, and biochemical variables were recorded, and micro- and macrovascular complications were documented. AAC was assessed on 118 interpretable lateral lumbar spine radiographs using the Kauppila score. The association between AAC and ischemic heart disease (IHD) was analyzed with logistic regression (age-adjusted model and parsimonious model).
Results
Women comprised 56% of the cohort; median age was 62 years, T2DM duration 8 years, and median HbA1c 7.1%. Macrovascular complications occurred in 16.7%: IHD 9.6%, cerebrovascular disease 2.9%, and peripheral arterial disease 6.2%. AAC was present in 30.5% and was more frequent among those with IHD (66.7% vs. 26.4%; p=0.004). In the age-adjusted model, AAC showed a trend toward association with IHD (OR 3.44; 95% CI 0.883–13.40; p=0.075). In the parsimonious model, AAC remained an independent predictor (OR 5.25; 95% CI 1.42–19.40; p=0.0128). Model performance: AUC 0.81 (95% CI 0.71–0.91), good calibration (Hosmer-Lemeshow p=0.246), and Brier score 0.081.
Discussion
In T2DM, AAC was associated with a higher probability of IHD and may serve as an accessible marker of subclinical cardiovascular risk. Prospective studies are warranted to confirm causality and define its prognostic utility.
Zitieren
APA
Vanesa, P., D., G. A., S., D. R., Isabel, L. M., S., O. F., H., B. F., & Lilian, A. (2025). Calcificación de aorta abdominal en diabetes mellitus tipo 2: asociación con cardiopatía isquémica y desempeño de un modelo clínico. EndoAr. https://doi.org/10.65640/4a1ne585
Vancouver
Vanesa P, D. GA, S. DR, Isabel LM, S. OF, H. BF, et al. Calcificación de aorta abdominal en diabetes mellitus tipo 2: asociación con cardiopatía isquémica y desempeño de un modelo clínico. EndoAr. 2025. doi:10.65640/4a1ne585
BibTeX
@article{Vanesa2025,
author = {Vanesa, Pitasny and D., González Adrián and S., Dobry Raquel and Isabel, López María and S., Otal Fernanda and H., Bordenave Fernando and Lilian, Anca},
title = {Calcificación de aorta abdominal en diabetes mellitus tipo 2: asociación con cardiopatía isquémica y desempeño de un modelo clínico},
journal = {EndoAr},
year = {2025},
doi = {10.65640/4a1ne585}
}
EUVIMED